Ipamorelin Research & Studies
We track 20 published, PubMed-indexed studies for Ipamorelin, spanning 1999 to 2026. The research below includes 5 reviews, 13 research articles, 2 clinical trials.
These summaries are for educational purposes. Research findings, particularly from preclinical studies, may not translate to human outcomes. Always consult a qualified healthcare provider before making decisions based on this information.
5
Reviews
13
Research Articles
2
Clinical Trials
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.
ReviewRahman OF, Lee SJ, Seeds WA|J Am Acad Orthop Surg Glob Res Rev|2026
Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians.
ReviewMayfield CK, Bolia IK, et al.|Am J Sports Med|2026
The influence of ghrelin agonist ipamorelin acetate on the hypothalamic-pituitary-testicular axis in a cichlid fish, Oreochromis mossambicus.
Research ArticleGouda M, Ganesh CB|Anim Reprod Sci|2024
The growth hormone secretagogue receptor 1a agonists, anamorelin and ipamorelin, inhibit cisplatin-induced weight loss in ferrets: Anamorelin also exhibits anti-emetic effects via a central mechanism.
Research ArticleLu Z, Ngan MP, et al.|Physiol Behav|2024
Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males.
ReviewSinha DK, Balasubramanian A, et al.|Transl Androl Urol|2020
Attenuation of Visceral and Somatic Nociception by Ghrelin Mimetics.
Research ArticleN Mohammadi E, Louwies T, et al.|J Exp Pharmacol|2020
Glycine-modified growth hormone secretagogues identified in seized doping material.
Research ArticleGajda PM, Holm NB, et al.|Drug Test Anal|2019
Analysis of new growth promoting black market products.
Research ArticleKrug O, Thomas A, et al.|Growth Horm IGF Res|2018
A stable meta-carborane enables the generation of boron-rich peptide agonists targeting the ghrelin receptor.
Research ArticleWorm DJ, Els-Heindl S, et al.|J Pept Sci|2018
Peptidomimetic growth hormone secretagogue derivatives for positron emission tomography imaging of the ghrelin receptor.
Research ArticleFowkes MM, Lalonde T, et al.|Eur J Med Chem|2018
Structure-activity relationship for peptídic growth hormone secretagogues.
Research ArticleFerro P, Krotov G, et al.|Drug Test Anal|2017
Doping control container for urine stabilization: a pilot study.
Research ArticleTsivou M, Giannadaki E, et al.|Drug Test Anal|2017
Simplifying and expanding the screening for peptides <2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry.
Research ArticleThomas A, Görgens C, et al.|J Sep Sci|2016
Solid-phase extraction of small biologically active peptides on cartridges and microelution 96-well plates from human urine.
Research ArticleSemenistaya E, Zvereva I, et al.|Drug Test Anal|2016
Determination of growth hormone releasing peptides metabolites in human urine after nasal administration of GHRP-1, GHRP-2, GHRP-6, Hexarelin, and Ipamorelin.
Research ArticleSemenistaya E, Zvereva I, et al.|Drug Test Anal|2015
Detection of GHRP-2 and GHRP-6 in urine samples from athletes.
Research ArticleCox HD, Hughes CM, Eichner D|Drug Test Anal|2015
Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients.
Clinical TrialBeck DE, Sweeney WB, et al.|Int J Colorectal Dis|2014
[Ghrelin-related drugs: clinical perspectives].
ReviewShimatsu A|Nihon Rinsho|2004
[Structure-activity relationship of ghrelin].
ReviewMinamitake Y|Nihon Rinsho|2004
Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers.
Clinical TrialGobburu JV, Agersø H, et al.|Pharm Res|1999